Announcements Trials

Browse Landscape

Status

Completed 9 Unknown 3 Terminated 3 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Glioblastoma 9 Recurrence 1 Oligodendroglioma 1 Neoplasms 1 Neoplasm Recurrence, Local 1 Medulloblastoma 1 Lymphoma, Large B-Cell, Diffuse 1 Glioma 1 Central Nervous System Neoplasms 1 Burkitt Lymphoma 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Temozolomide 10 Specimen Handling 6 Radiotherapy 6 Magnetic Resonance Spectroscopy 6 pembrolizumab 3 Bevacizumab 3 trametinib 2 Surgical Procedures, Operative 2 Radiation 2 Magnetic Resonance Imaging 2 Leukapheresis 2 Genetic Therapy 2 Fluorodeoxyglucose F18 2 Biopsy 2 vorasidenib 1 trastuzumab deruxtecan 1 ribociclib 1 regorafenib 1 olutasidenib 1 mirdametinib 1 lorlatinib 1 dabrafenib 1 apixaban 1 aflibercept 1 abexinostat 1 Vinblastine 1 Tretinoin 1 Therapies, Investigational 1 Restraint, Physical 1 Re-Irradiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Astrocytoma × Lomustine × Clear all

NCT06283927 2024-02-28

RECSUR

Erasmus Medical Center

Astrocytoma, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡